Volume 6 Issue 4, Apr 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 4, Apr 2021:
Research Highlight
Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
Catarina R. Almeida  ORCID: orcid.org/0000-0001-6670-6004,Beatriz H. Ferreira &Iola F. Duarte  ORCID: orcid.org/0000-0003-4289-9256